Literature DB >> 4741452

Haemolysis related to mitral valve replacement with the Beall valve prosthesis.

B J Henderson, A S Mitha, B T Le Roux, M S Gotsman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4741452      PMCID： PMC470064          DOI： 10.1136/thx.28.4.488

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  8 in total

1.  Mitral disc-valve variance.

Authors:  R B Berroya; F B Escano
Journal:  Thorax       Date:  1972-01       Impact factor: 9.139

2.  Factors influencing hemolysis in valve prosthesis.

Authors:  C Crexells; N Aerichide; Y Bonny; G Lepage; L Campeau
Journal:  Am Heart J       Date:  1972-08       Impact factor: 4.749

3.  Advantages of the Beall valve prosthesis.

Authors:  J H Vogel; B C Paton; H R Overy; G Pappas; D H Davies; S G Blount
Journal:  Chest       Date:  1971-03       Impact factor: 9.410

4.  Clinical experience with a dacron velour-covered teflon-disc mitral-valve prosthesis.

Authors:  A C eall; R D Bloodwell; D Liotta; D A Cooley; M E De Bakey
Journal:  Ann Thorac Surg       Date:  1968-05       Impact factor: 4.330

5.  Results of mitral valve replacement with dacron velour-covered teflon-disc prosthesis.

Authors:  A C Beall; D L Bricker; B J Messmer
Journal:  Ann Thorac Surg       Date:  1970-03       Impact factor: 4.330

6.  Systemic embolism and the Beall mitral valve prosthesis.

Authors:  R P Javier; F J Hildner; W Berry; J J Greenberg; P Samet
Journal:  Ann Thorac Surg       Date:  1970-07       Impact factor: 4.330

7.  The experimental and clinical results of a modified cage disc mitral prosthesis.

Authors:  G J Magovern; F J Begg; E M Kent; W B Cushing; M L Gerber; D L Fisher
Journal:  J Thorac Cardiovasc Surg       Date:  1970-01       Impact factor: 5.209

8.  Hemolysis following mitral valve replacement with the Beall valve prosthesis.

Authors:  J C Williams; C R Vernon; G R Daicoff; T D Bartley; M W Wheat; H W Ramsey
Journal:  J Thorac Cardiovasc Surg       Date:  1971-03       Impact factor: 5.209
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.